RDA Financial Network’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.63M Sell
33,632
-1,064
-3% -$83.2K 0.71% 32
2025
Q1
$2.51M Buy
34,696
+926
+3% +$67.1K 0.75% 34
2024
Q4
$2.5M Buy
33,770
+523
+2% +$38.7K 0.73% 31
2024
Q3
$2.19M Buy
33,247
+2,417
+8% +$159K 0.68% 37
2024
Q2
$2.85M Buy
30,830
+6,357
+26% +$587K 0.93% 25
2024
Q1
$2.34M Buy
24,473
+986
+4% +$94.2K 0.8% 34
2023
Q4
$1.79M Buy
23,487
+2,729
+13% +$208K 0.68% 43
2023
Q3
$1.44M Buy
20,758
+928
+5% +$64.3K 0.62% 50
2023
Q2
$1.87M Sell
19,830
-300
-1% -$28.3K 0.79% 38
2023
Q1
$1.67M Buy
20,130
+714
+4% +$59.1K 0.76% 39
2022
Q4
$1.45M Sell
19,416
-1,305
-6% -$97.4K 0.73% 43
2022
Q3
$1.71M Buy
20,721
+184
+0.9% +$15.2K 0.93% 28
2022
Q2
$1.95M Buy
20,537
+461
+2% +$43.8K 0.99% 27
2022
Q1
$2.36M Buy
20,076
+1,202
+6% +$141K 1% 28
2021
Q4
$2.45M Buy
18,874
+390
+2% +$50.5K 1% 30
2021
Q3
$2.09M Buy
18,484
+117
+0.6% +$13.2K 0.92% 35
2021
Q2
$1.9M Buy
18,367
+563
+3% +$58.3K 0.84% 37
2021
Q1
$1.49M Buy
17,804
+961
+6% +$80.4K 0.64% 47
2020
Q4
$1.54M Buy
16,843
+2,051
+14% +$187K 0.69% 43
2020
Q3
$1.18M Buy
14,792
+471
+3% +$37.6K 0.54% 53
2020
Q2
$990K Buy
14,321
+827
+6% +$57.2K 0.49% 58
2020
Q1
$848K Buy
13,494
+1,014
+8% +$63.7K 0.51% 53
2019
Q4
$968K Buy
12,480
+111
+0.9% +$8.61K 0.39% 64
2019
Q3
$1M Sell
12,369
-570
-4% -$46.3K 0.43% 64
2019
Q2
$805K Buy
12,939
+840
+7% +$52.3K 0.36% 77
2019
Q1
$763K Buy
+12,099
New +$763K 0.36% 74